Skip to main content
. 2019 May 24;11(10):3138–3155. doi: 10.18632/aging.101970

Table 3. Secondary cognitive outcomes specific for MCI.

  Treatment T0 T1 T2 Between-groups comparison
(Treatment)
 
TMT-A (sec.) PT 95.6±15 82±12.2 94±17.3 ★✦☆✧
CT 87.6±28.2 97±47.1 97.1±36.3
CTRL 111.8±64.9 149.1±68.8 180.7±62.6 ▲ ■
TMT-B (sec.) PT 209.1±48.7 190.1±30.6 195.7±39.8 ★✦☆✧
CT 193.9±56.5 173.1±53.3 215.2±76.5
CTRL 233±67.2 297.3±71 331.4±54.7 ▲ ■
RBMT (0-212) PT 79±29.1 93.6±35.6 81.7±37 ★✦☆✧
CT 77±30.3 95.1±31.4 74.5±36.2
CTRL 66.2±22.3 51.6±25.4 38.3±21.1 ▲ ■

Data are given ad mean ± standard deviation. Abbreviations: PT: Physical Treatment group; CT: Cognitive Treatment group; CTRL: Control group. TMT: Trail Making Test; RBMT: Rivermead Behavioral Memory Test; FAB: Frontal Assessment Battery; IADL: Instrumental Activity of Daily Living; NPI: Neuropsychiatric Inventory. T0: Pre-Treatment assessment; T1: Post-Treatment assessment; T2: Follow-p assessment.

Within-group comparison significant results (p ≤ 0.05): ▲ T0-T1; ■ T0-T2.

Between-groups significant results (p ≤ 0.05): ★ T1 PT vs T1 CTRL; ✦ T1 CT vs T1 CTRL; ☆ T2 PT vs T2 CTRL; ✧ T2 CT vs T2 CTRL